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Abstract Titin (also known as connectin) is a giant filamentous 
protein that spans the distance between the Z- and M-lines of the 
vertebrate muscle sarcomere and plays a fundamental role in the 
generation of passive tension. Titin has been shown to bind 
strongly to myosin, making it tightly associated to the thick 
filament in the sarcomere. Recent observations have suggested 
the possibility that titin also interacts with actin, implying further 
functions of titin in muscle contraction. We show --  using in vitro 
motility and binding assays --  that native titin interacts with both 
f'damentous actin and reconstituted thin filaments. The interac- 
tion results in the inhibition of the f'daments' in vitro motility. 
Furthermore, the titin-thin f'dament interaction occurs in a 
calcium-dependent manner: increased calcium results in en- 
hanced binding of thin filaments to titin and greater suppression 
of in vitro motility. 
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I. Introduction 
Titin (also known as connectin) is a 3-million-dalton pro- 
tein - -  the largest protein known to date - -  that constitutes 
about 10% of the total muscle protein [1,2,4]. Titin's role in 
muscle function has so far been thought to be mostly me- 
chanic: being anchored to the Z-line and to the thick fila- 
ments of the A-band (via its strong myosin-binding property) 
it generates passive tension when the sarcomere is stretched 
[3,5,6,13]. In invertebrate muscles [14-16] and in the non-mus- 
cle cytoplasm [17], however, where such structural constraints 
are different or absent, titin's function remains elusive. Recent 
studies have shown that, beyond its strong affinity for myosin, 
titin also binds several other muscle proteins [7,8,9,10]. Of a 
particular interest is its binding to actin, because this interac- 
tion could potentially provide clues to titin's elusive functions. 
Indeed, the thin filament of the cardiac muscle I-band has 
been proposed to be a complex containing titin [18], non- 
muscle (cellular) titin has been shown to co-localize with the 
actin-rich stress fibers [19], and a strong association has been 
demonstrated between F-actin and cloned cardiac titin frag- 
ments [11] leading to the inhibition of actomyosin in vitro 
motility [12]. Interaction between native titin and F-actin or 
the structurally and functionally more complex thin filament, 
however, has not been demonstrated. We tested the possibility 
of interaction between native titin and F-actin/thin filament 
using in vitro heavy meromyosin (HMM)-supported motility 
assays and in vitro titin-F-actin/thin filament binding assays. 
*Corresponding author. Fax: (1) (509) 335-4650; 
E-maih granzier@unicorn.it.wsu.edu 
Our results indicate that titin can interact with both unregu- 
lated actin filaments and reconstituted thin filaments, which 
results in the inhibition of the filaments' in vitro motility. The 
titin-thin filament association was found to be enhanced upon 
increasing the free calcium concentration. 
2. Materials and methods 
2.1. Preparation of proteins 
Actin, myosin and heavy meromyosin (HMM) were purified ac- 
cording to established methods [20-22]. F-Actin was fluorescently 
labelled with molar excess of tetramethyl-rhodamine-isothiocyanate- 
phalloidin (Molecular Probes, Eugene, OR). HMM was actin-affinity 
purified prior to use in the in vitro assay to remove irreversible rigor 
heads [22]. Titin was prepared from rabbit back muscle (longissimus 
dorsi) essentially according to the method of Soteriou et al. [7]. The 
final chromatography stage of the procedure resulted in fractions 
containing a mixture of T1 and T2 titin, followed by fractions con- 
taining T2 only [23]. For the in vitro motility and binding assays we 
used the first fraction devoid of T1. Purity of titin was determined by 
SDS-polyacrylamide g l electrophoresis u ing 2.35 12% gels [24]. 
2.2. Reconstitution f thin filaments 
Thin filaments were reconstituted from purified actin and tropo- 
myosin-troponin (Tm Tn) complex. Tm-Tn complex was prepared 
essentially according to Sata et al. [25]. In order to obtain homoge- 
nous reconstitution of the thin filament we carried out the reconstitu- 
tion by incubating F-actin (1 mg/ml) and Tm-Tn complex (2 mg/ml) 
at 40°C for 10 min followed by slow cooling (0.2°C/rain) to 10°C [25]. 
Alternatively, we mixed Tm-Tn complex with G-actin followed by 
polymerization of actin [26]. The two different methods yielded iden- 
tical results, pCa was calculated by the computer program of Fabiato 
[27] and adjusted by adding CaCI2. 
2.3. In vitro motility assay 
The in vitro motility assay was carried out essentially according to 
Kron et al. [22]. Fluorescent actin filaments were visualized by using a 
Nikon Diaphot 300 inverted epifluorescence microscope quipped 
with rhodamine interference filter set (Nikon) and a 64×, 1.4 NA 
oil-immersion objective (Nikon), and using a microchannel-plate in- 
tensified CCD camera (ICCD-100F, VideoScope International Ltd., 
Sterling, VA). The detected images were recorded on a Hi8mm VCR 
(SONY EV-S7000), and subsequently digitized by an LG-3 frame 
grabber board (Scion Corporation, Frederick, MD) in an Apple 
Power Macintosh 6100/60 computer using image analysis software 
(Scion Image Version 1.57c, based on NIH Image, Wayne Rasband, 
NIH, Bethesda). Experiments were carried out at 30°C, adjusted by 
using a temperature-regulated copper microscope stage and a copper 
coil around the objective in which water was circulated by a heating/ 
cooling thermostat (VWR Scientific, Seattle, WA). The flow-through 
microchamber was identical to the one used by Kellermayer et al. [28] 
with an internal volume of ~ 10 ~1. First, 100 /al of HMM-titin 
mixture in 0.6 M KCI-Assay Buffer (AB, 25 mM imidazole-HCl, 25 
mM KC1, 4 mM MgC12, 1 mM EGTA, 1 mM DTT, pH 7.4) was 
pipetted through the microchamber and incubated at room tempera- 
ture for 1 min. HMM concentration was varied between 40 100 ~tg/ 
ml, and titin concentration between 0.29-427 p_g/ml. Molar ratios 
were calculated assuming a molecular weight of 360 kDa for HMM 
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[21] and 2000 kDa for T2 [2]. Titin was omitted from the control 
experiment. Non-specific binding sites were blocked by washing in 
100 gl of 0.5 mg/ml bovine serum albumin (BSA) in AB buffer. 
Fluorescent actin filaments were then added, at a concentration of 
70 ng/ml, and allowed to bind to the HMM titin-coated surface for 
1 min. The flow-cell was then washed with 100 gl of AB buffer sup- 
plemented with 6 mg/ml D-glucose, 40 gg/ml catalase, 200 gg/ml glu- 
cose oxidase, and 100 mM [3-mercaptoethanol to reduce photobleach- 
ing. Filament movement was initiated by the infusion of 1 mM ATP. 
The velocity of the actin filaments was measured on digitized video 
sequences (usually 30 frames) by user-developed macro programs. 
Velocity was calculated by automatically following the centroid posi- 
tion of a selected filament as a function of time. For spatial calibra- 
tion we used a 10-gm optical grating (VWR Scientific, Seattle, WA). 
Results were plotted either as histograms (Fig. lb) or as mean velo- 
cities with standard error of the mean for all filaments (including 
immobile) in 5-10 microscope fields of view (Fig. 3a and b). 
2.4. In vitro microscopic binding assay 
The interaction between titin and actin/thin filaments was studied in 
an in vitro microscopic binding assay. In the assay, the amount of 
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Fig. 1. Effect of titin on in vitro actin-filament motility. With in- 
creasing tit in-to-HMM molar ratio the velocity of the mobile actin- 
filaments decreased and the number of immobile filaments increased. 
The actual t it in-to-HMM ratios are indicated on the right side of 
the figure. 
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Fig. 2. In vitro F-actin-titin binding assay. (a) Actin-filament bind- 
ing to increasing densities of titin. Titin density on the nitrocellulose 
surface was adjusted by varying the solution titin concentration in 
the range of 1.2-400 gg/ml. The extent of filament binding was 
measured as the mean total actin-filament length per field of view 
versus titin concentration in solution. Total filament length in- 
creased with increasing titin concentration. Above 400 gg/ml titin 
concentration, the nitrocellulose surface apparently became satu- 
rated. Data were fit with the hyperbolic function flx)=ax/(b+x), 
where a is the maximal total filament length at saturating titin con- 
centrations and b is the titin concentration at 50% saturation. The 
inset shows a representative fluorescence microscopic image of actin 
filaments bound to a surface coated with titin. Scale bar=10 gm. (b) 
Actin-filament binding to the titin-coated nitrocellulose surface as a 
function of ionic strength (F/2). The nitrocellulose surface was 
coated with titin at a solution concentration of 400 I.tg/ml. Data 
were fit with the logistic function flx)=(a-d)/[l+(x/c)b]+d, where a 
and d are the maximal and minimal total filament lengths, respec- 
tively, b is the slope parameter, and c is the ionic strength at the 
half-maximal value of total filament length. 
fluorescent actin/thin filaments bound to a titin-coated nitrocellulose 
surface was assessed by measuring the total filament length per field of 
view. Measuring the total filament length instead of counting the 
number of filaments provided a better estimate of the titin-bound 
actin/thin filament because mean filament length increased with in- 
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creasing titin concentration, i dicating that a single filament may bind 
to several titin molecules. Titin, diluted in 0.6 M KC1-AB buffer was 
added to the microchamber and allowed to bind to the nitrocellulose 
surface for one minute. Non-specific binding sites were then blocked 
with 0.5 mg/ml BSA in AB buffer. Fluorescent actin/thin filaments, at 
a concentration f 70 ng/ml were then added and allowed to bind to 
the titin-coated surface for one minute. Unbound filaments were 
washed away with AB buffer supplemented with the oxygen-scavenger 
enzyme system (see above). Filament length was measured by either 
manually tracing the filaments using the freehand tool of the image 
analysis oftware or by using a user-developed macro program that 
automatically traced filaments and measured their length in a se- 
quence of digitized images. Ionic strength was adjusted by washing 
in solution containing progressively increasing concentrations of KCI. 
Ionic strength was calculated using the computer program of Fabiato 
[27]. At an ionic strength above ~ 150 mM, filaments began to par- 
tially dissociate from the titin-coated surface. This resulted in actin 
filaments with segments wiggling in solution plus segments remaining 
immobile. Dissociated, wiggling segments were excluded from the 
length measurement by frame averaging (8 16 frames) and threshold- 
ing. 
2.5. Capillary binding assay 
Thin filament-titin capillary binding assay was carried according to 
Li et al. [12]. Nitrocellulose-coated glass capillaries (Drummond 
Scientific Co., Broomall, PA; internal volume 87 ~1) were filled with 
titin (100 p.g/ml) and incubated at room temperature for 1 min. Non- 
specific binding sites were blocked with BSA (0.5 mg/ml in AB buffer). 
Thin filaments (unlabeled) were then added, with an actin concentra- 
tion of 100 ~tg/ml, and the pCa adjusted to either 5.5 or 6.5, and the 
ionic strength to either 42 mM or 150 mM. After one minute, the 
unbound thin filaments were washed out with 900 ~1 buffer (identical 
to the one in which the thin filaments were diluted), and the contents 
of the capillary were solubilized and analyzed for protein composition 
by electrophoresis using a 2.6-12% polyacrylamide g l [24]. For pro- 
tein detection, ammoniacal silver staining was used [24]. Titin was 
omitted from the negative control. Gel scanning was carried out using 
a UC1260 color scanner (UMAX Data System Inc., Fremont, CA) in 
the transparency mode at 600 dpi resolution. 
3. Results and discussion 
3.1. Interaction between ative titin and F-actin 
The effect of titin on in vitro motility was studied by fol- 
lowing the movement of fluorescent actin filaments on a lawn 
composed of a mixture of HMM and native titin. To exclude 
the effect of the known actin-binding titin segment (near the 
Z-line) [29] we used the T2 (also known as [3-connectin) por- 
tion of the molecule from which the near-Z-line segment is 
absent [2]. The addition of titin in the in vitro motility assay 
resulted in a decrease in velocity of the moving filaments and 
in an increase in the number of immobile filaments (Fig. 1). 
The decrease in velocity increased with increasing molar ratio 
of native titin to HMM, similarly to previous experiments 
with genetically expressed titin fragments [12]. 
The inhibition of actin-filament motility by titin could be 
caused by the tethering of the filaments, as proposed in the 
case of titin fragments by Li et al. [12]. To test for this, we 
carried out an in vitro actin-titin binding assay (Fig. 2). The 
nitrocellulose-coated surface of the solution chamber used for 
the in vitro assay was coated with varying concentrations of 
titin. Then, following the blocking of non-specific binding 
sites with BSA, fluorescent actin filaments were allowed to 
bind to the surface. The degree of actin binding to titin was 
assessed by measuring the total length of all actin filaments 
per microscopic field of view of the titin-coated surface. Our 
results howed that F-actin binds to native titin, evidenced by 
the numerous actin filaments bound to the titin-coated surface 
(Fig. 2a, inset). The total filament length increased with in- 
creasing surface density of titin (Fig. 2a). Since titin binds 
actin filaments trongly under our experimental conditions, 
the idea that titin inhibits in vitro actin-filament motility by 
tethering the filaments is well supported. 
In vitro motility assays are generally carried out at ionic 
strengths (typically 30-50 mM) lower than what is considered 
to be physiological (,~ 180 mM) [30]. To test whether the 
demonstrated actin-titin association will occur under ionic 
conditions resembling physiological, we measured the degree 
of actin-titin interaction at increased ionic strengths (Fig. 2b). 
The binding of F-actin to titin was not affected by increasing 
ionic strength up to ,~ 150 mM. Above ,~ 150 mM, actin 
filaments tarted to dissociate from the titin-coated surface: 
partially attached, wiggling filaments began to appear, indi- 
cating that the filaments, originally bound at several sites, are 
held at a reduced number of attachment points. The actin 
filaments were found to be tethered strongly at the focal 
points of attachment; he linkage withstood solution flow, 
and allowed for actin-filament rotation around the attachment 
point. Upon further increase of ionic strength, the majority of 
actin filaments completely dissociated from the titin-coated 
surface. The ionic strength at the half-maximal value of the 
total filament length was 361.7 mM (+21.52, S.E.M.). Thus, 
the actin titin interaction may have physiological significance 
because it occurs at ionic strengths considered to be physio- 
logical. 
3.2. Interaction between ative titin and reconstituted th& 
filaments 
In the intact muscle sarcomere, regulatory proteins (tropo- 
nin, tropomyosin) are associated with actin, forming the thin 
filament. To study whether the presence of regulatory proteins 
influences the actin-titin interaction, we replaced pure F-actin 
with reconstituted thin filaments and carried out calcium(p- 
Ca)-dependent in vitro motility assays. In the in vitro thin 
filament-HMM motility assay, at pCa 4.2 (fully activated 
state), increasing titin density resulted in the progressive in- 
hibition of motility, as shown by reduced filament velocities 
(Fig. 3a). Thus, titin also inhibits thin-filament motility. To 
measure the effect of titin at different levels of activation, thin- 
filament velocity was measured at varying pCa levels (Fig. 
3b). In the absence of titin, motility was present even at 
high pCa, similarly to the recent observations of Fraser and 
Marston [31]. The minimal velocities (in the pCa range of 6.5- 
6.1) for the control and titin experiments were 0.59 (+0.16, 
S.E.M.) and 0.45 lam/s (+0.18, S.E.M.), respectively. The dif- 
ference between these velocities is statistically insignificant 
(Student's t-test, P<0.05). Thus, the effect of titin on motility 
at high pCa was negligible. At low pCa (5.9-5.5), the inhibi- 
tion of motility became pronounced: the maximal velocities 
for the control and titin experiments were 3.17 (+0.13, 
S.E.M.) and 1.51 ~tm/s (+0.20, S.E.M.), respectively. The dif- 
ference between the velocities is statistically significant (Stu- 
dent's t-test, P<0.05). Inhibition of motility at low pCa (pCa 
5.9 5.4) reached ,~ 50%. Thus, the inhibition of thin-filament 
motility by titin is calcium dependent. 
The greater degree of inhibition at low pCa could be indir- 
ectly caused by the higher mean filament velocity leading to 
larger number of contacts between titin and the thin filament 
per unit time (see model proposed by Li et al. [12]). Alterna- 
tively, low pCa may have a direct effect resulting in an in- 
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creased affinity of the thin filament to titin. To test the effect 
of velocity on the degree of motility inhibition by titin, we 
varied filament velocity by an independent method, by chan- 
ging the temperature in the in vitro motility assay. Increasing 
temperature results in increasing velocities [32]. Thus, if inhi- 
bition of motility by titin is enhanced at increased filament 
velocities, greater degree of inhibition is expected upon raising 
the temperature. In the acto-HMM in vitro motility assay, 
using a titin-to-HMM molar ratio of 0.0015 we found a 
74% (+6, S.E.M.) inhibition of motility at 20°C. In contrast, 
at 30°C, the degree of inhibition was only 41% (+10, S.E.M.). 
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Since the degree of motility inhibition by titin decreased upon 
raising temperature (hence increasing mean velocity), the idea 
that the increased inhibition of thin-filament motility at low 
pCa is caused by the increased mean velocity is not supported. 
Rather, the calcium dependence of motility inhibition suggests 
that at low pCa the thin filament's affinity to titin is increased. 
To further test whether the thin filament-titin affinity is 
calcium dependent, we carried out in vitro thin filament-titin 
binding assays as a function of ionic strength at high (6.5) and 
low (5.5) pCa. Raising the ionic strength results in the disso- 
ciation of actin filaments from titin (see Fig. 2b). Thus, the 
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Fig. 3. Interaction between titin and reconstituted thin filaments. (a) Filament velocity as a function of titin-to-HMM molar ratio. The titin-to- 
HMM ratios used in this experiment were: 0.0004, 0.001, 0.002 and 0.01. Experiments were carried out at activating pCa levels (pCa 4.2, ex- 
cept for the titin-to-HMM ratio of 0.01, which was carried out at pCa 5.5). Filament velocity decreased as the titin-to-HMM molar ratio in- 
creased. (b) Velocity-pCa relationship in the absence ('control') and the presence ('titin') of titin. The titin-to-HMM ratio was 0.01. Data were 
fit with the logistic function used in Fig. 2c. (c) In vitro thin filament-titin binding assay at pCa 5.5 and 6.5 as a function of ionic strength. De- 
gree of binding was measured as the total length of thin filaments bound to a field of view of the titin-coated surface, as described under Fig. 
2. Data were fit with the logistic function used in Fig. 2c. Broken line is data (from Fig. 2b) for unregulated actin filaments. (d) SDS-polyacry- 
lamide gel showing the results of the thin filament-titin capillary binding assay. Left-side panel shows the photograph of the gel and the right- 
side the scan of lanes 7 10. The lanes correspond to the following: (1) rabbit m. longissimus dorsi protein profile, (2) actin, (3) reconstituted 
thin filament, (4) titin, (5) BSA, (6) negative control: thin filaments in the absence of titin, (7) thin filaments added to titin at I"/2 of 42 mM 
and pCa 5.5, (8) at F/2 of 42 mM and pCa 6.5, (9) at 1"/2 of 150 mM and pCa 5.5, and (10) at F/2 of 150 mM and pCa 6.5. The reduced 
Tm+TnT to actin ratios in lanes 7 and 8, compared to that of the control (lane 3) and lane 9, are likely to be caused by the reduced affinity 
of tropomyosin to F-actin at low ionic strength [33]. 
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Fig. 3 (continued). 
ionic-strength dependence of thin filament-titin binding pro- 
vides means to compare the affinity of thin filaments to titin at 
different pCa levels. If thin filaments bind titin stronger at low 
pCa, they are expected to stay attached to the titin-coated 
surface at higher ionic strengths than in the case of high 
pCa. Fig. 3c summarizes our observations. At high pCa 
(6.5), thin filaments began dissociating at an ionic strength 
as low as ,~ 100 mM. At low pCa (5.5), however, thin fila- 
ment dissociation began only at ,~200 mM ionic strength. 
The ionic strengths at the half-maximal values of total fila- 
ment length were 205.2 (+19.9, S.E.M.) and 299.5 mM (_+20.2, 
S.E.M.) for pCa 6.5 and pCa 5.5, respectively. Thus, the in 
vitro binding assay supports the idea that at low pCa the 
affinity of thin filaments is greater for titin than at high pCa 
levels. To confirm the results of the in vitro binding assay by 
an alternative method, we carried out a thin filament-titin 
capillary binding assay [12]. Thin filaments were added to titin 
attached to the nitrocellulose-coated inner surface of a glass 
capillary. The contents of the capillary were then solubilized 
and analyzed for protein by SDS-polyacrylamide g l electro- 
phoresis [24]. Binding of thin filaments to titin was analyzed in 
the cases of pCa 5.5 and 6.5 and ionic strengths of 42 mM 
(identical to that used in the in vitro motility assay) and 150 
mM. The gel analysis (Fig. 3d) showed that, at an ionic 
strength of 150 mM, larger quantity of thin-filament protein 
bound to a given amount of titin at pCa 5.5, than at pCa 6.5. 
The finding provides a qualitative support for the results of 
the in vitro motility and binding assays, and point to the 
stronger thin-filament titin interaction at low pCa. 
Our observations indicate that - in the experimental environ- 
ment of the in vitro motility assay - native titin is able to bind 
both actin and reconstituted thin filaments. This binding re- 
suits in the inhibition of the motility of actin or thin filaments 
over HMM. The molecular mechanism of the movement in- 
hibition is likely to be the tethering of actin or thin filaments 
to the nitrocellulose surface, a possibility suggested previously 
in the case of cardiac titin fragments [12], and supported by 
our in vitro binding assays. The possibility of titin tethering 
the actin or thin filaments to HMM is unlikely since titin has 
been shown not to bind to HMM [7,12]. The Ca-dependent in 
vitro motility and binding assays point to an increased affinity 
of thin filaments to titin at low pCa. Possibly, titin binds to F- 
actin at sites covered by tropomyosin in the relaxed state 
(high pCa). These sites might then become exposed as the 
pCa is lowered, allowing titin to access the actin filament. 
Our observation that, for a given titin-to-HMM ratio, the 
reconstituted thin filament slides faster than the unregulated 
actin filament lends support for this mechanism. An alterna- 
tive mechanism ight be a direct effect of pCa on titin struc- 
ture, affecting its affinity to the thin filament. Whatever the 
actual molecular mechanism, the observation that native titin 
influences in vitro thin filament motility suggests that titin's 
role may extend beyond the generation of passive tension, to a 
possible regulatory role in muscle contraction and cell moti- 
lity. Such a regulatory role might involve the calcium-depen- 
dent modulation of filament sliding in the sarcomere. 
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